DiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Up 58.9% in February

DiaSorin S.p.A. (OTCMKTS:DSRLF) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 218,900 shares, a growth of 58.9% from the February 13th total of 137,800 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 2,189.0 days. Currently, 0.4% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, UBS Group cut shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.

DiaSorin Stock Performance

Shares of DiaSorin stock opened at $109.60 on Monday. DiaSorin has a 1-year low of $100.26 and a 1-year high of $109.60. The firm has a fifty day simple moving average of $104.96 and a 200-day simple moving average of $104.11.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.